Tekka lists on NYSE Alternext

Paris - NYSE Euronext today announced the listing of tekka, specialized in the design, production and marketing of instruments and products for dental surgery, orthodontics and cranio-maxillo-facial surgery, on NYSE Alternext in Paris.

Founded in 2000, tekka harnesses innovative technologies to produce prostheses and surgical implants made from titanium and bioresorbable materials. The company handles every stage in production, winning Oseo’s “innovative business” label for its expertise, and distributes its products in 20 countries. It employs 119 people at five subsidiaries.

Tekka (ticker code: ALTKA) was listed through admission to trading of 2,745,760 existing shares and 1,036,867 shares issued under a Global Offering[1]. Following conversion of bonds into shares, an additional 203,585 new shares were issued. The Global Offering raised a total of €11.25 million.

The admission and issue price of tekka shares was set at €10.85. Market capitalization stood at €43.25 million on the day of listing

“We are delighted to welcome tekka to NYSE Alternext,” said Ronald Kent, Group Executive Vice President and Head of International Listings at NYSE Euronext, adding “NYSE Alternext is a market well suited to innovative businesses seeking outstanding visibility in the financial community as they pursue their growth strategies.”

Thierry Rota, Chairman & CEO of tekka, added: “We are very happy with our listing on NYSE Alternext. We would like to thank all of our new shareholders, along with our partners and staff, who placed their trust in us and are joining in our development. The funds raised will enable us to accelerate growth in France and abroad, expand our product offering, and consolidate our position as one of the market’s top contenders in dental implants, as well as raise our profile in the financial community.”

In just over five years, €2.4 billion have been raised on NYSE Alternext, half on the secondary market, by 156 companies from countries including Belgium, Canada, China, France, Italy, Luxembourg, the Netherlands, Spain, the UK and the US. Altogether, their market capitalization totals €4.2 billion.

About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company’s exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext’s equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world’s equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world’s second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: www.nyx.com.

About tekka
Founded in 2000, tekka designs, manufactures and sells innovative medical devices for cranio-maxillo-facial surgery, orthodontics and dental implants. Thanks to its disruptive approach based on an innovative sales strategy, attractive price positioning and unparalleled service standards, tekka has taken only five years to establish itself as France’s no. 1 specialist in cranio-maxillo-facial surgery and no. 2 in dental implants (based on volumes)(1).

tekka - ZI de Sacuny - 118, av Marcel Mérieux, 69530 Brignais, France www.tekka.com
(1) Source: Company

[1] The Global Offering was made up of an Open Price Public Offering and a Global Placement with institutional investors in France and other countries.


Provider : Euronext Paris